Full-Time

Senior Enterprise Customer Success Manager

Confirmed live in the last 24 hours

Calibrate

Calibrate

201-500 employees

Health-tech startup for sustainable weight loss

Compensation Overview

$120k - $135k/yr

Senior

Remote in USA

Remote-first ways of working, with the flexibility to work from any state.

Category
Customer Success
Sales & Account Management
Requirements
  • 5+ years of relevant professional experience supporting clients and managing an account portfolio.
  • Prior commercial experience managing health and wellness benefits to employers.
  • An expert at communicating and presenting data to tell meaningful and actionable stories that result in value recognition and retention.
  • Ability to communicate client feedback and sentiment to internal stakeholders.
  • Strong written and verbal communication skills, with extreme attention to detail.
  • Comfort building strong interpersonal relationships with cross-functional stakeholders.
  • Experience in a fast-paced startup environment and the ability to successfully operate in ambiguity with a bias for action.
  • Passionate about innovation in digital health.
  • Must be authorized to work in the United States.
Responsibilities
  • Foster and manage strong, strategic, long-term client relationships with client decision-makers and benefit brokers.
  • Thoughtfully drive customer satisfaction, enrollments, and program value with our partnership and enterprise clients.
  • Assisted in developing a more robust account strategy by creating strategic plans and growth strategies.
  • Provide important client updates, report performance metrics, and service level agreements, conduct effective meetings, and lead compelling quarterly business reviews.
  • Identify underlying customer needs and leverage company resources to meet those needs, ensuring client retention, expansion, and advocacy for the enterprise portfolio.
  • Contribute to the development and sharing of best practices that strengthen the Calibrate Customer Success team.

Calibrate focuses on sustainable weight loss by improving metabolic health instead of relying on traditional dieting methods. Their program combines gradual habit changes with medication that targets underlying biological factors. This approach has reportedly led to a 15% sustained weight loss in real-world settings, distinguishing Calibrate from other weight loss programs. The company operates on a subscription model, often supported by employers as part of employee wellness initiatives, but is also available to individuals. Calibrate uses GLP-1 medications that mimic natural hormones to enhance metabolic function, reduce inflammation, and lower cardiovascular risks. Their goal is to provide an easy-to-maintain program that effectively promotes long-term health and wellness.

Company Size

201-500

Company Stage

Growth Equity (Venture Capital)

Total Funding

$156.6M

Headquarters

New York City, New York

Founded

2020

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing interest in personalized medicine boosts demand for Calibrate's tailored weight loss approach.
  • Increasing employer investment in wellness programs expands Calibrate's corporate market.
  • Telehealth models enable Calibrate to reach a broader audience effectively.

What critics are saying

  • Reliance on GLP-1 medications leads to patient complaints and refund issues.
  • Selling to Madryn Asset Management suggests potential financial instability.
  • New CEO may introduce strategic changes disrupting current operations.

What makes Calibrate unique

  • Calibrate combines FDA-approved medication with a holistic curriculum for weight loss.
  • The program offers 1:1 virtual coaching sessions for personalized support.
  • Calibrate focuses on metabolic health rather than traditional dieting methods.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive salary with opportunity for equity in an early stage, high growth business

Generous paid time off, including an all-company holiday over Thanksgiving week

Calibrate-funded health benefits (medical, dental, vision) - starting at zero cost to you

One Medical membership and Teladoc virtual care

Fertility, gynecology, and wellness services through Kindbody

Therapy on your time with a free year of Talkspace membership

Health advocacy and assistance services through Health Advocate

Commuter benefits, ClassPass memberships, and gym memberships for post-pandemic life

Remote team with a headquarters in NYC

Competitive Paid Parental Leave for parents

Growth & Insights and Company News

Headcount

6 month growth

-2%

1 year growth

-3%

2 year growth

-8%
Leads on Trees
Sep 21st, 2024
Calibrate Secures $100M in Series B Funding to Revolutionize Weight Treatment

Calibrate secures $100M in series B funding to revolutionize weight treatment.

Hit Consultant
Feb 9th, 2024
Calibrate Appoints Rob Macnaughton As New Ceo

Rob MacNaughhton, CEO at CalibrateWhat You Should Know:– Calibrate, the leading clinician-guided and value-based obesity treatment program, today announced the appointment of Rob MacNaughton as its new Chief Executive Officer.– Calibrate’s strategic direction under MacNaughton’s leadership and the OptumRx partnership position the company for significant growth and a positive impact on both individual and corporate healthcare landscapes.MacNaughton Bio/BackgroundMacNaughton boasts a distinguished track record in launching new healthcare ventures, overseeing product development, and scaling operations. Prior to Calibrate, MacNaughton served as Venture Chair at Redesign Health, overseeing the launch and growth of several healthcare delivery and technology brands. His previous roles include CEO positions at Curve Health and Nurse Grid, and Chief Product Officer at Cambia Health Solutions, a multi-state Blue Cross Blue Shield payor.“Obesity is the largest category of chronic disease and one of the biggest drivers of healthcare spending. I’m honored to join a company at the forefront of value-based obesity care and a business that is clearly committed to addressing the epidemic head on while helping employers and insurers manage soaring costs,” said Calibrate CEO, Rob MacNaughton. “Our commercial momentum is stronger than ever, and we are confident we will continue to collaborate with industry leaders to deliver best-in-class sustained outcomes.”

Endpoints News
Nov 1st, 2023
Weight loss startup Calibrate raises $29M as part of private equity restructuring

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Calibrate, the weight loss startup that rose in popularity with the rise of GLP-1 medications only to struggle to get patients access to those medications — leading to patient complaints and refunds

Endpoints News
Nov 1st, 2023
Weight loss start­up Cal­i­brate rais­es $29M as part of pri­vate eq­ui­ty re­struc­tur­ing

Weight loss start­up Cal­i­brate rais­es $29M as part of pri­vate eq­ui­ty re­struc­tur­ing.

Business Insider
Oct 20th, 2023
Exclusive: Weight-loss startup Calibrate is selling itself to a private equity firm as patient complaints mount

Weight-loss startup Calibrate is selling itself to the private equity firm Madryn Asset Management, Insider has learned.